BERMAN ROBERT ANDREW 4
4 · Hancock Jaffe Laboratories, Inc. · Filed Jul 21, 2020
Insider Transaction Report
Form 4
BERMAN ROBERT ANDREW
DirectorCEO
Transactions
- Other
Stock Option
2020-07-18−1,080,207→ 0 totalExercise: $4.99From: 2018-04-26Exp: 2028-04-26→ Common Stock (1,080,207 underlying) - Award
Stock Option
2020-07-18+1,080,207→ 1,080,207 totalExercise: $0.40Exp: 2030-07-18→ Common Stock (1,080,207 underlying)
Footnotes (2)
- [F1]The Board terminated the common stock options pursuant to Section 17.15 of the Amended and Restated 2016 Omnibus Incentive Plan.
- [F2]The common stock options were issued, and vested upon grant.